Vall d'Hebron Hospital
If you are the contact person for this centre and you wish to make any changes, please contact us.
Endocrinologist and coordinator of the Obesity Unit at Vall d'Hebron Hospital.
Director of the Clinical and Molecular Genetics Department at the Vall d'Hebron Hospital in Barcelona
Oncologist at the Colon Cancer Unit of Vall d'Hebron Hospital.
Director of the Digestive System Research Unit at the Vall d'Hebron University Hospital in Barcelona and former president of the Spanish Society of Microbiota, Probiotics and Prebiotics (SEMiPyP)
Head of the Oncology Department of the Vall d'Hebron University Hospital of Barcelona and Director of the Vall d'Hebron Institute of Oncology
Specialist in obstetrics and maternal-fetal medicine at the Obstetrics Department of the Vall d'Hebron Hospital.
Director of the Clinical Neuroimmunology Laboratory at the Multiple Sclerosis Centre of Catalonia (Cemcat) and neurologist at the Vall d'Hebron University Hospital in Barcelona
Specialist in Pneumology at the Vall d'Hebron Hospital in Barcelona
Head of the Laboratory of Gene Therapy in Neurodegenerative Diseases of the VHIR-UAB Mixed Unit
Doctor in the Paediatric Oncology and Haematology Department at Vall d'Hebron Hospital and associate professor in the Paediatrics Department at the Autonomous University of Barcelona
Between 2018 and 2020, a pilot programme conducted neonatal genetic screening of children born in Australia for spinal muscular atrophy, allowing treatment to begin early. A study just published in The Lancet Child & Adolescent Health looks at their condition at two years of age and concludes that they had better movement ability, including the ability to walk, compared to children diagnosed once they develop symptoms. According to the authors, the findings justify further implementation of neonatal screening for the disease.
Bubble boy syndrome is a very serious condition caused by combined immunodeficiency. It is sometimes caused by certain mutations in the gene that codes for the Artemis protein. A phase I-II clinical trial has tested a gene therapy that adds a correct copy of the gene. The results are published in the journal NEJM.
A pioneering phase 1 clinical trial has tested a type of cancer immunotherapy. Researchers have modified patients' own T-lymphocyte receptors using the CRISPR tool to direct them against specific targets on their own tumours. The results are published in the journal Nature.
Research to be published in the journal Nature identifies and characterizes the cells responsible for relapse in colon cancer. In addition, it proposes revising clinical guidelines and administering immunotherapy before surgery to try to avoid them
Research published in the journal Cell has found a link between the intake of the sweeteners saccharin and sucralose with changes in the gut microbiota that may lead to altered glucose metabolism.
During confinement, pregnant women suffered more stress than usual among pregnant women, according to a study conducted at Vall d'Hebron Hospital. A new result along the same lines also finds effects on the brain development of the foetus. But the period of neurodevelopment spans childhood and adolescence, so there are many opportunities to favourably influence this process.
A review published today in The Journal of Headache and Pain concludes that 52% of the population is affected by a headache each year, with 14% reporting migraines.